Tag: metabolomics market growth

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What is the Expected Growth Rate of the Metabolomics Market from 2024 to 2033?

The metabolomics market has expanded rapidly in recent years. It is anticipated to grow from $3.11 billion in 2023 to $3.6 billion in 2024, reflecting a CAGR of 15.8%. The historic growth is fueled by advancements in healthcare, drug discovery, disease biomarker identification, and nutrition and food science.

The metabolomics market is projected to grow to $6.68 billion by 2028, with a CAGR of 16.7%. The growth is driven by personalized healthcare, drug safety and efficacy, microbiome research, agricultural applications, and regenerative medicine. Key trends include integration with other omics, targeted metabolomics, single-cell metabolomics, AI and data analytics, and point-of-care testing.

Claim Your Free Sample of the Global Metabolomics Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=2497&type=smp

What Key Factors Are Fueling the Growth of the Metabolomics Market?

The rising prevalence of cancer is driving the growth of the metabolomics market. Metabolomics helps identify biomarkers for cancer diagnosis and treatment response. In 2021, cancer was responsible for 10 million deaths worldwide. Metabolomics technologies, such as nuclear magnetic resonance (NMR) and mass spectrometry (MS), are being increasingly used for early cancer detection, driving the market forward.

What Are the Major Segments of the Metabolomics Market?

1) By Product & Service: Metabolomics Instruments, Metabolomics Bioinformatics Tools & Services

2) By Indication: Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors of Metabolism, Other Indications

3) By Application: Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics, Personalized Medicine, Other Applications

Subsegments: Separation Techniques, Detection Techniques, Bioinformatics Tools and Database, Bioinformatics Services

What New Trends Are Transforming the Metabolomics Market?

Machine learning is becoming popular in metabolomics for improving the efficiency of data analysis. Machine learning algorithms help automate complex processes and ensure accurate results. Companies like Bio-Rad Laboratories and Metabolon Inc. are using machine learning for metabolism analysis and metabolic pathway modeling. For instance, MeltDB 2.0 aids in the integration and analysis of metabolomics data.

Order Now for Fast Delivery of Your Metabolomics Market Report!

https://www.thebusinessresearchcompany.com/report/metabolomics-global-market-report

Which Regions Are Driving Growth in the Metabolomics Market?

North America was the largest region in the metabolomics market in 2023. Western Europe was the second largest region in the metabolomics market. The regions covered in the metabolomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The Metabolomics Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the metabolomics market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Metabolomics Market Include

1. Metabolomics Market Executive Summary

2. Metabolomics Market Segments

3. Metabolomics Market Size And Template Market Growth Rate

4. Key Metabolomics Market Trends

5. Major Metabolomics Market Drivers

……

25. Key Mergers And Acquisitions In The Metabolomics Market

26. Top Metabolomics Companies

27. Metabolomics Market Opportunities And Strategies

28. Metabolomics Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Hematology Diagnostic Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hematology-diagnostic-devices-and-equipment-global-market-report

Bioinformatics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/bioinformatics-global-market-report

#Microbiome Global Market Report 20243

#https://www.thebusinessresearchcompany.com/report/microbiomes-global-market-report3

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

According to The Business Research Company’s Metabolomics Global Market Report 2024, the metabolomics market is expected to show promising growth in the forecast period.

The metabolomics market has witnessed a remarkable surge in recent years, with its size catapulting from $3.11 billion in 2023 to an anticipated $3.6 billion in 2024, boasting a robust Compound Annual Growth Rate (CAGR) of 15.8%. This expansion in the historic period is accredited to various factors, such as healthcare advancements, drug discovery and development, disease biomarker identification, contributions from academic and research institutions, and breakthroughs in nutrition and food science.

Future Projections
Looking ahead, the metabolomics market is poised for even more substantial growth, with a projected size of $6.68 billion in 2028, demonstrating a promising CAGR of 16.7%. The forecasted period’s growth is driven by key factors including personalized healthcare, drug safety and efficacy, microbiome and gut health exploration, environmental and agricultural applications, and advancements in regenerative medicine. Major trends to watch in this period encompass integration with other omics, targeted metabolomics, single-cell metabolomics, as well as the increasing role of data analytics and artificial intelligence, alongside a rise in point-of-care testing.

Cancer Prevalence Fueling Metabolomics Innovations

Global Impact of Cancer
A major catalyst for the metabolomics market surge is the escalating prevalence of cancer worldwide. Metabolomics plays a pivotal role in early cancer diagnosis, screening potential biomarkers to gauge drug responsiveness and facilitate timely intervention. Shockingly, according to a 2021 WebMD report, a staggering 10 million people succumbed to cancer globally. In the U.S. alone, the American Cancer Society projects 1.9 million new cases and 609,360 deaths in 2022, averaging 1,670 fatalities daily.

Metabolomics Approaches in Cancer Research
Metabolomics techniques, such as nuclear magnetic resonance (NMR) and mass spectrometry (MS), have become integral in cancer research. Renowned companies like Metabolon Inc., Bruker Corp., and others have embraced metabolomics, leveraging tools for early cancer detection and therapeutic advancements. In a bid to combat this global health crisis, these companies are at the forefront of utilizing metabolomics to drive breakthroughs in cancer diagnostics and treatment.

View More On The Metabolomics Market Report 2024 – https://www.thebusinessresearchcompany.com/report/metabolomics-global-market-report

Elevating Metabolomics Excellence: Thermo Fisher Scientific’s Collaborative Approach with the University of California

Strategic Partnerships in Metabolomics
Major players in the metabolomics market are strategically aligning to fortify their positions. Thermo Fisher Scientific Inc., a leading entity in the field, collaborated with the University of California to establish the Center of Excellence in Clinical Metabolomics. Launched in July 2021, this collaborative research initiative aims to standardize efforts within the metabolomics community, fostering large-scale cohort investigations and clinical research.

Center of Excellence Objectives
The Center of Excellence in Clinical Metabolomics, a joint venture between Thermo Fisher Scientific Inc. and the University of California, focuses on providing large-scale population-based metabolic analysis. This initiative includes standardized procedures, workflows for end-to-end metabolic profiling, customized chromatography-mass spectrometry (LC-MS) techniques, analytical control protocols, and training sessions for metabolomics professionals. The University of California, a public grant research university, brings its academic prowess to this transformative partnership.

Strategic Acquisition Boosts Clinical Microbiomics Metabolomics Capabilities

Innovation Through Acquisition
In a noteworthy move, Denmark-based Clinical Microbiomics acquired MS-Omics in October 2022, augmenting its metabolomics capabilities. The undisclosed acquisition added specialized metabolic profiling offerings to Clinical Microbiomics’ portfolio, advancing its systems biology platform and facilitating global research initiatives. MS-Omics, the acquired company, further solidifies Denmark’s position as a hub for metabolomics excellence.

Market Segmentation
The metabolomics market is intricately segmented to cater to diverse needs. The segmentation includes:

1. By Product & Service: Metabolomics Instruments, Metabolomics Bioinformatics Tools & Services
2. By Indication: Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors of Metabolism, Other Indications
3. By Application: Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics, Personalized Medicine, Other Applications

Regional Dominance
In 2023, North America emerged as the largest region in the metabolomics market, further underscoring the global significance and prominence of this evolving field.

Request A Sample Of The Global Metabolomics Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=2497&type=smp